Troy A. McEachron, PhD, explores osteosarcoma’s interactions with its microenvironment and advocates for genetic diversity in research to ensure that findings are applicable to all populations.
Stories of Progress, Inspiration & Support
Our Experts & Specialists
Insights from our SAB members and physicians
Award-winning researcher explains how his work seeks to better understand osteosarcoma’s genomic instability to uncover novel treatments for the most aggressive types of the disease.
Sign Up to Receive The Frontline
at vero eos et accusamus et iusto odio dignis simos duccimus qui blanditis
We never sell or share your information.
Your donation provides immediate and long-term support to osteosarcoma patients.